Table 1.
Samples | Analytes | Linearity Equation | R2 | Linear Range | LOD | LOQ | Precision (% RSD) | Enrichment Factor | |
---|---|---|---|---|---|---|---|---|---|
(ng mL−1) | (ng mL−1) | (ng mL−1) | Intra-Day (n = 5) |
Inter-Day (n = 5) |
|||||
Sheng-maiyin oral liquid | Transfluthrin | y = 82.78x + 754.83 | 0.9991 | 0.05–200.00 | 0.011 | 0.035 | 3.68 | 2.61 | 45.16 |
Fenpropathrin | y = 98.49x − 799.59 | 0.9992 | 0.05–200.00 | 0.007 | 0.022 | 3.06 | 2.98 | 47.67 | |
Fenvalerate | y = 65.76x + 1722.24 | 0.9997 | 0.05–200.00 | 0.017 | 0.049 | 4.62 | 1.06 | 47.50 | |
Etofenprox | y = 79.72x + 762.23 | 0.9995 | 0.05–200.00 | 0.014 | 0.040 | 3.60 | 3.02 | 48.89 | |
Silafluofen | y = 87.77x + 2137.18 | 0.9999 | 0.05–200.00 | 0.010 | 0.032 | 2.87 | 2.46 | 51.07 | |
Qutan-ling oral liquid | Transfluthrin | y = 71.09x − 550.41 | 0.9997 | 0.05–200.00 | 0.016 | 0.047 | 3.42 | 2.73 | 46.83 |
Fenpropathrin | y = 80.01x + 679.88 | 0.9992 | 0.05–200.00 | 0.013 | 0.038 | 3.47 | 1.98 | 45.84 | |
Fenvalerate | y = 58.10x + 1250.09 | 0.9998 | 0.05–200.00 | 0.018 | 0.057 | 3.17 | 2.44 | 47.85 | |
Etofenprox | y = 74.87x + 951.04 | 0.9994 | 0.05–200.00 | 0.015 | 0.045 | 2.79 | 1.83 | 46.33 | |
Silafluofen | y = 79.30x + 1325.92 | 0.9995 | 0.05–200.00 | 0.014 | 0.042 | 3.69 | 2.48 | 46.73 | |
Yimuc-ao oral liquid | Transfluthrin | y = 81.17x + 499.39 | 0.9993 | 0.05–200.00 | 0.012 | 0.037 | 2.68 | 1.65 | 50.48 |
Fenpropathrin | y = 95.35x − 780.63 | 0.9999 | 0.05–200.00 | 0.008 | 0.025 | 3.29 | 2.66 | 43.67 | |
Fenvalerate | y = 71.39x + 140.27 | 0.9992 | 0.05–200.00 | 0.016 | 0.049 | 2.62 | 2.16 | 45.49 | |
Etofenprox | y = 79.73x + 1875.92 | 0.9995 | 0.05–200.00 | 0.014 | 0.043 | 4.16 | 2.70 | 45.77 | |
Silafluofen | y = 90.96x + 763.42 | 0.9996 | 0.05–200.00 | 0.009 | 0.029 | 2.44 | 1.98 | 46.98 |